Comparative effectiveness of frame-based and mask-based Gamma Knife stereotactic radiosurgery in brain metastases: A 509 patient meta-analysis

Purpose Stereotactic Radiosurgery (SRS) is the primary treatment for patients with limited numbers of small brain metastases. Head fixation is usually performed with framed-based (FB) fixation; however, mask-based (MB) fixation has emerged as a less invasive alternative. A comparative meta-analysis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuro-oncology 2024-10, Vol.170 (1), p.53-66
Hauptverfasser: Pichardo-Rojas, Pavel S., Vázquez-Alva, Diego, Alvarez-Castro, José A., Flores-Patiño, Brandon, Escalante-Ordoñez, Enrique, Haro-Adame, Julio A., Espinosa-Temaxte, Carlos E., Amsbaugh, Mark, Blanco, Angel I., Trifiletti, Daniel M., Esquenazi, Yoshua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Stereotactic Radiosurgery (SRS) is the primary treatment for patients with limited numbers of small brain metastases. Head fixation is usually performed with framed-based (FB) fixation; however, mask-based (MB) fixation has emerged as a less invasive alternative. A comparative meta-analysis between both approaches has not been performed. Methods Databases were searched until August 28th, 2023, to identify studies comparing MB and FB SRS in the treatment of brain metastases. Our outcomes of interest included local tumor control (LTC), radiation necrosis (RN), mortality, and treatment time (TT). Mean difference (MD), risk ratio (RR), and hazard ratio (HR) were used for statistical comparisons. Results From 295 articles initially identified, six studies (1 clinical trial) involving 509 patients were included. LTC revealed comparable RR at 6-months (RR = 0.95[95%CI = 0.89–1.01], p  = 0.12) and a marginal benefit in FB SRS at 1-year (RR = 0.87[95%CI = 0.78–0.96], p  = 0.005). However, in oligometastases exclusively treated with single-fraction SRS, LTC was similar among groups (RR = 0.92 [95%CI = 0.89–1.0], p  = 0.30). Similarly, in patients with oligometastases treated with single-fraction SRS, RN (HR = 1.69; 95%CI = 0.72–3.97, p  = 0.22), TT (MD = -29.64; 95%CI = -80.38–21.10, p  = 0.25), and mortality were similar among groups (RR = 0.62; 95%CI = 0.22–1.76, p  = 0.37). Conclusion Our findings suggest that FB and MB SRS, particularly oligometastases treated with single-fraction, are comparable in terms of LTC, RN, TT, and mortality. Further research is essential to draw definitive conclusions.
ISSN:0167-594X
1573-7373
1573-7373
DOI:10.1007/s11060-024-04738-8